Reduction in systolic blood pressure in hypertensive individuals and oxidized LDL in 93 overweight individuals with CVD risk.
Reduction in URTI severity and sick days in physically fit adults aged 40 and older at 1,000 mg/day for 12 weeks.
In upper respiratory tract infections (URTI) incidence in male cyclists after intensive exercise.
In blood pressure in stage 1 hypertensive patients with Quercetin supplementation (730 mg/d) for 28 days.